Bonti

Bonti

Bonti

Bonti is a rapidly emerging biotech company. Our lead product candidate is EB001, is used for both Therapeutic & Aesthetic needs.
Suggest edits
Type
B2c
Founded
2015
Raised
$27.2M
Follow us
Companies in the same industry
Alexa global traffic share
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2

Add info
Add round
23 Jan 2018
$15,500,000
Venture capital (Series C)

Former Botox Bosses Raise $15.5 Million for Biotech Startup Bonti

VentureWire
+1
19 Apr 2017
$11,700,000
Venture capital (Series B)
City Hill Ventures, Colt Ventures, RBV Capital

Bonti Raises $11.7 Million in an Oversubscribed Series B Financing to Advance Development of Lead Product EB-001

businesswire